China State Construction International Holdings logo

3311 - China State Construction International Holdings News Story

HK$5.33 0.0  0.8%

Last Trade - 9:08am

Sector
Industrials
Size
Mid Cap
Market Cap £2.49bn
Enterprise Value £6.16bn
Revenue £5.84bn
Position in Universe 498th / 6087

Hong Kong shares rise on vaccine hopes, Sino-U.S. tensions cap gains

Dec 11 (Reuters) - Hong Kong stocks tracked other Asian
market higher as progress on COVID-19 vaccines boosted
sentiment, although gains were capped due to a flare up in
Sino-U.S. tensions. 
    
** The Hang Seng index  .HSI  rose 0.4 to end at 26,505.87,
while the China Enterprises Index  .HSCE  gained 0.4% to
10,452.50.   
    
** Asian markets were buoyed by optimism that imminent
vaccinations would fuel economic recovery. U.S. authorities
voted overwhelmingly to endorse emergency use of Pfizer's
coronavirus vaccine, while doses of a COVID-19 vaccine made by
China's Sinovac Biotech  SVA.O  are rolling off a Brazilian
production line.  urn:newsml:reuters.com:*:nL1N2IQ353  urn:newsml:reuters.com:*:nL1N2IQ10J
    
** But the Hong Kong market is clouded by signs of deterioration
in Sino-U.S. relationship as the U.S. Federal Communications
Commission (FCC) begun the process of revoking China Telecom's
authorization to operate in the United States.  urn:newsml:reuters.com:*:nL1N2IQ22N
    
** S&P Dow Jones Indices on Thursday became the second major
index provider to remove some Chinese companies from its index
products following a Trump administration executive order. FTSE
Russell made a similar move last week, while rival index
publisher MSCI is expected to follow suit.  urn:newsml:reuters.com:*:nL1N2IQ0J0
    
** Hong Kong-listed shares of the U.S.-blacklisted companies,
including CRRC  1766.HK , China Communications Construction Co
 1800.HK  and China State Constrution  3311.HK  all fell on
Friday.    

 (Reporting by the Shanghai Newsroom; Editing by Rashmi Aich)
 ((luoyan.liu@thomsonreuters.com; Reuters Messaging:
luoyan.liu.thomsonreuters.com@reuters.net))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.